Ph.D. Alan J. Main

Insider Reports History

Signature
/s/ Alan J. Main, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ph.D. Alan J. Main:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Common Stock 339,104 $227,200 $0.6700 28 Feb 2025 Direct
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Restricted Stock Units 136,487 $91,446 $0.6700 28 Feb 2025 Direct
LEXICON PHARMACEUTICALS, INC. EVP, Innov & Chem Sciences Stock Option (Right to Buy) 753,090 13 Feb 2025 Direct

Insider Reports Filed by Ph.D. Alan J. Main

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2025 7 -$29,101 4 EVP, Innov & Chem Sciences 03 Mar 2025, 16:32
LXRX LEXICON PHARMACEUTICALS, INC. 13 Feb 2025 2 $0 4 EVP, Innov & Chem Sciences 18 Feb 2025, 16:21
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2024 7 -$63,949 4 EVP, Innov & Chem Sciences 29 Feb 2024, 16:30
LXRX LEXICON PHARMACEUTICALS, INC. 08 Feb 2024 2 $0 4 EVP, Innov & Chem Sciences 12 Feb 2024, 16:16
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2023 7 -$45,453 4 EVP, Innov & Chem Sciences 01 Mar 2023, 15:53
LXRX LEXICON PHARMACEUTICALS, INC. 09 Feb 2023 2 $0 4 EVP, Innov & Chem Sciences 13 Feb 2023, 16:01
LXRX LEXICON PHARMACEUTICALS, INC. 28 Feb 2022 7 -$56,305 4 EVP, Innov & Chem Sciences 28 Feb 2022, 18:16
LXRX LEXICON PHARMACEUTICALS, INC. 10 Feb 2022 2 $0 4 EVP, Innov & Chem Sciences 14 Feb 2022, 15:10